Terry Dagnon - Net Worth and Insider Trading
Terry Dagnon Net Worth
The estimated net worth of Terry Dagnon is at least $55,510 dollars as of 2024-12-27. Terry Dagnon is the COO of Outlook Therapeutics Inc and owns about 32,653 shares of Outlook Therapeutics Inc (OTLK) stock worth over $55,510. Details can be seen in Terry Dagnon's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Terry Dagnon has not made any transactions after 2023-04-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Terry Dagnon
Terry Dagnon Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Terry Dagnon owns 1 companies in total, including Outlook Therapeutics Inc (OTLK) .
Click here to see the complete history of Terry Dagnon’s form 4 insider trades.
Insider Ownership Summary of Terry Dagnon
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| OTLK | Outlook Therapeutics Inc | 2023-04-20 | Chief Operating Officer |
Terry Dagnon Latest Holdings Summary
Terry Dagnon currently owns a total of 1 stock. Terry Dagnon owns 32,653 shares of Outlook Therapeutics Inc (OTLK) as of April 20, 2023, with a value of $55,510.
Latest Holdings of Terry Dagnon
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| OTLK | Outlook Therapeutics Inc | 2023-04-20 | 32,653 | 1.70 | 55,510 |
Holding Weightings of Terry Dagnon
Terry Dagnon Form 4 Trading Tracker
According to the SEC Form 4 filings, Terry Dagnon has made a total of 6 transactions in Outlook Therapeutics Inc (OTLK) over the past 5 years, including 3 buys and 3 sells. The most-recent trade in Outlook Therapeutics Inc is the sale of 26,000 shares on April 20, 2023, which brought Terry Dagnon around $592,800.
Insider Trading History of Terry Dagnon
- 1
Terry Dagnon Trading Performance
GuruFocus tracks the stock performance after each of Terry Dagnon's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Terry Dagnon is 25.37%. GuruFocus also compares Terry Dagnon's trading performance to market benchmark return within the same time period. The performance of stocks bought by Terry Dagnon within 3 months outperforms 3 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Terry Dagnon's insider trading performs compared to the benchmark.
Performance of Terry Dagnon
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 6.24 | | | | | |
| Relative Return to S&P 500(%) | 1.51 | | | | | |
Terry Dagnon Ownership Network
Terry Dagnon Owned Company Details
What does Outlook Therapeutics Inc do?
Who are the key executives at Outlook Therapeutics Inc?
Terry Dagnon is the Chief Operating Officer of Outlook Therapeutics Inc. Other key executives at Outlook Therapeutics Inc include CFO and Secretary Lawrence A Kenyon , Chief Commercial Officer Jeff Evanson , and director & CEO and President Trenary C Russell Iii .
Outlook Therapeutics Inc (OTLK) Insider Trades Summary
Over the past 18 months, Terry Dagnon made no insider transaction in Outlook Therapeutics Inc (OTLK). Other recent insider transactions involving Outlook Therapeutics Inc (OTLK) include a net purchase of 62,484 shares made by Jeff Evanson , a net purchase of 5,000 shares made by Lawrence A Kenyon , and a net purchase of 1,882 shares made by Yezan Munther Haddadin .
In summary, during the past 3 months, insiders sold 0 shares of Outlook Therapeutics Inc (OTLK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Outlook Therapeutics Inc (OTLK) were sold and 10,006 shares were bought by its insiders, resulting in a net purchase of 10,006 shares.
Outlook Therapeutics Inc (OTLK)'s detailed insider trading history can be found in Insider Trading Tracker table.
Outlook Therapeutics Inc Insider Transactions
Terry Dagnon Mailing Address
Above is the net worth, insider trading, and ownership report for Terry Dagnon. You might contact Terry Dagnon via mailing address: C/o Oncobiologics, Inc., 7 Clarke Drive, Cranbury Nj 08512.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
